title: Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia.
abstract: Sildenafil, a phosphodiesterase-5 inhibitor, is a controversial treatment option for pulmonary arterial hypertension (PAH), a significant complication of bronchopulmonary dysplasia (BPD). The objective of this study was to evaluate the use of sildenafil in infants with PAH secondary to BPD. This was a retrospective review of medical records of all premature infants with PAH associated with BPD treated with sildenafil between January 2009 and May 2013 in a level 3 neonatal intensive care unit. The primary outcomes were clinical response (20 % decreases in respiratory support score or oxygen requirements) and echocardiographic response (20 % decrease in tricuspid regurgitation gradient or change of at least 1° of septal flattening). Twenty-three infants were included in the study. Significant echocardiographic and clinical responses were, respectively, observed in 71 and 35 % of cases. Most clinical responses were observed in the first 48 h of treatment, and the median time to an echocardiographic response was of 19 days. The median dose of sildenafil used was 4.4 mg/kg/day, with a median time to reach the maximum dose of 9 days. Transient hypotension was the primary reported side effect, and it was observed in 44 % of our study population. Sildenafil treatment in patients with PAH secondary to BPD was associated with an echocardiographic improvement in the majority of patients, whereas clinical improvement was observed in a minority of patients. Many infants presented with transient hypotension during the course of the treatment. Further prospective studies are required to better assess safety and efficacy of this treatment in this population.
authors.affiliation: Department of Pediatrics, CHU Sainte-Justine, 3175 chemin de la Cote-Sainte-Catherine, Montreal, QC, H3T 1C5, Canada, mntrottierboucher@gmail.com.
authors.forename: M N
authors.initials: MN
authors.lastname: Trottier-Boucher
authors.forename: A
authors.initials: A
authors.lastname: Lapointe
authors.forename: J
authors.initials: J
authors.lastname: Malo
authors.forename: A
authors.initials: A
authors.lastname: Fournier
authors.forename: M J
authors.initials: MJ
authors.lastname: Raboisson
authors.forename: B
authors.initials: B
authors.lastname: Martin
authors.forename: A
authors.initials: A
authors.lastname: Moussa
mesh_terms: D001997:Bronchopulmonary Dysplasia / Q000150:complications* / Q000000981:diagnostic imaging; D004305:Dose-Response Relationship, Drug; D004452:Echocardiography; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D007022:Hypotension / Q000139:chemically induced / Q000453:epidemiology; D007223:Infant; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal; D008297:Male; D010100:Oxygen / Q000378:metabolism; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D056152:Respiratory Rate / Q000187:drug effects; D012189:Retrospective Studies; D000068677:Sildenafil Citrate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014262:Tricuspid Valve Insufficiency / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D000068677:Sildenafil Citrate; D010100:Oxygen
references.citation: J Pediatr. 2009 Dec;155(6):841-847.e1
references.pmid: 19836028
references.citation: Am J Respir Crit Care Med. 2015 Jan 1;191(1):87-95
references.pmid: 25389562
references.citation: Pediatrics. 2007 Dec;120(6):1260-9
references.pmid: 18055675
references.citation: Korean Circ J. 2010 Mar;40(3):131-6
references.pmid: 20339498
references.citation: Annu Rev Physiol. 2005;67:623-61
references.pmid: 15709973
references.citation: J Pediatr. 2009 Mar;154(3):379-84, 384.e1-2
references.pmid: 18950791
references.citation: J AAPOS. 2010 Apr;14(2):159-62
references.pmid: 20199882
references.citation: Pediatrics. 2005 Dec;116(6):1353-60
references.pmid: 16322158
references.citation: Pediatrics. 2006 Apr;117(4):1077-83
references.pmid: 16585301
references.citation: Am J Perinatol. 2010 Mar;27(3):225-30
references.pmid: 19866403
references.citation: Neonatology. 2012;101(1):40-6
references.pmid: 21791938
references.citation: Am J Obstet Gynecol. 2007 Feb;196(2):147.e1-8
references.pmid: 17306659
references.citation: Pediatrics. 2008 Feb;121(2):317-25
references.pmid: 18245423
references.citation: J Pediatr. 2008 Feb;152(2):291-3
references.pmid: 18206706
references.citation: J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S55-S66
references.pmid: 19555859
references.citation: Br J Ophthalmol. 2004 Feb;88(2):306-7
references.pmid: 14736800
references.citation: Arch Dis Child Fetal Neonatal Ed. 2010 Mar;95(2):F109-14
references.pmid: 19949232
references.citation: J Perinatol. 2011 Oct;31(10):635-40
references.pmid: 21311503
references.citation: J Perinatol. 2013 Mar;33(3):218-21
references.pmid: 22766743